Stam NJ, Vanderheyden P, van Alebeek C, Klomp J, de Boer T, van Delft AM, Olijve W (November 1994). «Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor». European Journal of Pharmacology269 (3): 339-348. PMID7895773. doi:10.1016/0922-4106(94)90042-6.
Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E (May 2001). «RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy». Neuropsychopharmacology24 (5): 478-491. PMID11282248. doi:10.1016/S0893-133X(00)00223-2.
Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M (December 2013). «Agomelatine versus other antidepressive agents for major depression». The Cochrane Database of Systematic Reviews (12): CD008851. PMID24343836. doi:10.1002/14651858.CD008851.pub2.
Berg KA, Harvey JA, Spampinato U, Clarke WP (December 2005). «Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors». Trends in Pharmacological Sciences26 (12): 625-630. PMID16269190. doi:10.1016/j.tips.2005.10.008.
Esposito E (February 2006). «Serotonin-dopamine interaction as a focus of novel antidepressant drugs». Current Drug Targets7 (2): 177-185. PMID16475959. doi:10.2174/138945006775515455.
Bubar MJ, Cunningham KA (2006). «Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence». Current Topics in Medicinal Chemistry6 (18): 1971-1985. PMID17017968. doi:10.2174/156802606778522131.
«Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors». Journal of Medicinal Chemistry57 (12): 5258-5269. June 2014. PMID24878222. doi:10.1021/jm5003292.Parámetro desconocido |vauthors= ignorado (ayuda)
«Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder». The Journal of Sexual Medicine8 (1): 15-27. January 2011. PMID20840530. doi:10.1111/j.1743-6109.2010.02032.x.Parámetro desconocido |vauthors= ignorado (ayuda)
Stam NJ, Vanderheyden P, van Alebeek C, Klomp J, de Boer T, van Delft AM, Olijve W (November 1994). «Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor». European Journal of Pharmacology269 (3): 339-348. PMID7895773. doi:10.1016/0922-4106(94)90042-6.
Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E (May 2001). «RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy». Neuropsychopharmacology24 (5): 478-491. PMID11282248. doi:10.1016/S0893-133X(00)00223-2.
Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M (December 2013). «Agomelatine versus other antidepressive agents for major depression». The Cochrane Database of Systematic Reviews (12): CD008851. PMID24343836. doi:10.1002/14651858.CD008851.pub2.
Berg KA, Harvey JA, Spampinato U, Clarke WP (December 2005). «Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors». Trends in Pharmacological Sciences26 (12): 625-630. PMID16269190. doi:10.1016/j.tips.2005.10.008.
Esposito E (February 2006). «Serotonin-dopamine interaction as a focus of novel antidepressant drugs». Current Drug Targets7 (2): 177-185. PMID16475959. doi:10.2174/138945006775515455.
Bubar MJ, Cunningham KA (2006). «Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence». Current Topics in Medicinal Chemistry6 (18): 1971-1985. PMID17017968. doi:10.2174/156802606778522131.
Jørgensen HS (November 2007). «Studies on the neuroendocrine role of serotonin». Danish Medical Bulletin54 (4): 266-288. PMID18208678.
«Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors». Journal of Medicinal Chemistry57 (12): 5258-5269. June 2014. PMID24878222. doi:10.1021/jm5003292.Parámetro desconocido |vauthors= ignorado (ayuda)
«Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder». The Journal of Sexual Medicine8 (1): 15-27. January 2011. PMID20840530. doi:10.1111/j.1743-6109.2010.02032.x.Parámetro desconocido |vauthors= ignorado (ayuda)
«PDSP Ki Database». Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Consultado el 14 de agosto de 2017.